Matthew F. Gorman

435 total citations
6 papers, 198 citations indexed

About

Matthew F. Gorman is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Matthew F. Gorman has authored 6 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Matthew F. Gorman's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Protein Degradation and Inhibitors (2 papers). Matthew F. Gorman is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Protein Degradation and Inhibitors (2 papers). Matthew F. Gorman collaborates with scholars based in United States and Canada. Matthew F. Gorman's co-authors include Jon Akutagawa, Benjamin S. Braun, Kevin Shannon, Wan Xing Hong, Natalya Lyubynska, Jennifer Lauchle, Richard H. Ko, Mignon L. Loh, Elena Eckroth and Richard Sposto and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Science Translational Medicine.

In The Last Decade

Matthew F. Gorman

6 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew F. Gorman United States	4	140	74	55	54	43	6	198
Michael T. Zimmerman United States	2	250 1.8×	89 1.2×	129 2.3×	55 1.0×	32 0.7×	2	282
Katayoon Shirneshan Germany	10	82 0.6×	118 1.6×	79 1.4×	30 0.6×	11 0.3×	21	271
Mayur Parihar India	9	111 0.8×	36 0.5×	93 1.7×	43 0.8×	51 1.2×	44	196
Mays Jawad United Kingdom	8	88 0.6×	109 1.5×	30 0.5×	20 0.4×	35 0.8×	13	187
Shlomzion Aumann Israel	7	53 0.4×	97 1.3×	25 0.5×	33 0.6×	51 1.2×	25	160
Frédéric Davi France	4	88 0.6×	41 0.6×	102 1.9×	39 0.7×	42 1.0×	6	180
Maria Chiara Abbenante Italy	7	83 0.6×	80 1.1×	66 1.2×	45 0.8×	45 1.0×	27	173
Maria López‐Pavía Spain	9	108 0.8×	102 1.4×	31 0.6×	31 0.6×	21 0.5×	21	183
Catherine E. Jenkins Canada	6	51 0.4×	140 1.9×	51 0.9×	11 0.2×	51 1.2×	8	222
Immacolata Attolico Italy	6	82 0.6×	27 0.4×	12 0.2×	47 0.9×	44 1.0×	17	146

Countries citing papers authored by Matthew F. Gorman

Since Specialization

Citations

This map shows the geographic impact of Matthew F. Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew F. Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew F. Gorman more than expected).

Fields of papers citing papers by Matthew F. Gorman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew F. Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew F. Gorman. The network helps show where Matthew F. Gorman may publish in the future.

Co-authorship network of co-authors of Matthew F. Gorman

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew F. Gorman. A scholar is included among the top collaborators of Matthew F. Gorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew F. Gorman. Matthew F. Gorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Chonat, Satheesh, Mary Risinger, Omar Niss, et al.. (2019). The Spectrum of SPTA1-Associated Hereditary Spherocytosis. Frontiers in Physiology. 10. 815–815. 34 indexed citations

2.

Gossai, Nathan, Michael R. Verneris, Nicole Karras, et al.. (2013). A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD). Bone Marrow Transplantation. 49(3). 440–442. 7 indexed citations

3.

Lyubynska, Natalya, Matthew F. Gorman, Jennifer Lauchle, et al.. (2011). A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice. Science Translational Medicine. 3(76). 76ra27–76ra27. 71 indexed citations

4.

Gorman, Matthew F., Lingyun Ji, Richard H. Ko, et al.. (2010). Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study. Pediatric Blood & Cancer. 55(3). 421–429. 83 indexed citations

5.

Gorman, Matthew F., Richard H. Ko, Richard Sposto, et al.. (2008). Retrospective analysis of children treated for relapsed acute myelogenous leukemia (rAML): A report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium. Journal of Clinical Oncology. 26(15_suppl). 10042–10042. 1 indexed citations

6.

Lauchle, Jennifer, Doan Le, Doris Kim, et al.. (2007). Mutations That Cooperate with Nf1 Inactivation in Leukemogenesis Influence Therapeutic Response to MEK Inhibition.. Blood. 110(11). 594–594. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact